2008年金融危机之后，全球经济增速开始放缓，而能源环境问题日益凸显，可持续发展面临巨大的挑战。与此同时，中国经济发展已经从单纯依靠速度的外延式增长转入以创新驱动、结构升级、节能环保等为特点的中高速平稳增长阶段。在经济新常态背景下，发展新能源产业是转变发展方式的内在要求，同时作为一个具有广阔发展前景的产业，新能源产业必将在新的增长阶段中大有作为。从世界范围看，各国近年来都高度重视新能源产业发展，加快推进能源革命。中国也在积极调整优化能源结构，大力培育新能源产业，提出了到2020年非化石能源消费比重提高到15%以上的目标。应该看到，这些年来我国新能源产业已取得了长足发展，但与国外相比仍有不小的差距。差距和问题既意味着巨大的潜力，也充分说明挖掘新能源这座“金矿”一定要有战略眼光。

Industrial microbiology is the branch of applied microbiology that involves the utilization of microorganisms in industrial processes such as pharmaceutical drugs development, vaccines production, industrial fermentation, wastewater treatment, and industrial chemical treatment. Industrial microbiological quality control includes the use of products and services for the identification and control of microbial species in the manufacturing of food items, beverages, drugs, cosmetics, biologics, and other industrial products in large quantities.

Currently, the field of radiation therapy is changing in terms of radiation type, and there are several changes in adoption patterns among its end-user segments. The end users are shifting from conventional radiation (Xray, or Cobalt-60, among others) to modern radiation such as a proton or heavy ion radiation. The increasing demand for modern radiation therapy systems has led to the increasing awareness of cancer/tumor treatments. The primary role of these systems is to shrink or destroy cancer/tumor depending on cancer/tumor type, stage, patient age, number of radiation sessions required, and many other factors. Radiation therapy can be divided primarily into external beam radiation therapy, also known as teletherapy, and internal beam radiation therapy, also known as brachytherapy. In the past decade, the definition of these technologies has expanded. Earlier the radiation therapy was only referred to as a simple therapy only done by the radiation beam. Now, radiation therapy includes internal radiation or external radiation combined with chemotherapy or open body surgery or combining various radiation therapy techniques such as IGRT, VMAT, and SRS to destroy or shrink cancer/ tumor. The ongoing trend of offering new radiation therapy systems which have proton or heavy ion beam, integration of two different radiation therapies, and integration of imaging technology with radiation therapy systems showcase the growing future of technological innovations and advancements in radiation therapy in the oncology field.

Direct-to-consumer genetic tests (DTC-GT) offers its consumers the ability to solve their individual genetic puzzle. The confluence of breakthroughs in genetic testing has not only decreased the time required to perform a genetic test but also has reduced the cost of conducting these tests. All these factors combined have given DTC-GT a lot of acceptance among the consumers. The major proponent of the DTC-GT market is the distribution channels opted by the companies. The companies are marketing these tests via online or retail channels. With the piqued advertisements of these tests through print, media, and the internet, the industry is gaining familiarity among consumers. Companies such as 23andme, Mapmygenome, Ancestry.com, EasyDNA, and 24Genetic are offering a large number of diversified services related to genealogy testing, health conditions, and traits. The journey of the DTC-GT initiates by a consumer ordering the test through an online channel. The sample collection kit is provided to the consumers. DNA sample such as saliva or oral swab is collected by the consumer and sent back to the organization for the analysis. Consumers get their test results on their online account within 3-5 weeks.

In its current form, 3D printing is most widely used in product development cycles. The time taken from idea generation to prototyping is vastly reduced by using 3D printing. As parts made through 3D printing are directly produced from software models, design creation and redesign challenges can be surmounted very easily by redesigning and uploading new files to the system. This reduces the costs associated with re-tooling, and trial and error costs are significantly reduced and even eliminated in some cases.

Advancements in R&D labs, especially in pharmaceutical and biotechnological laboratories, are likely to stoke the growth of the market during the forecast period. Growing focus on improving the efficiency of laboratories is also poised to help the market gain tremendous momentum over the coming years. Also, low implementation cost, efficient time management, and compliance with GDP, GCP, and GMP are the key factors escalating the demand for LIMS. Moreover, the rising practice of genome and DNA study and invitro ADME technologies is working in favor of the market. Associated advantages such as high precision and elimination of manual data transcription errors are also anticipated to provide a fillip to the market. Furthermore, the burgeoning popularity of cloud-based systems is projected to positively influence the growth of the overall market.

The global coding & marking market has witnessed significant transformations over the last decade, largely due to various innovations, regulatory standard modifications, growth of end-user industries, integration of automation in production, and the influx of several vendors across geographies, among others. Coding & marking solutions are handy for several reasons such as product tracking & traceability, identification, and tackling counterfeiting, among others. With the growth across end-user industries such as F&B, healthcare, chemicals & construction, electrical & electronics, and automotive, among others, the increase in product proliferation has become common. This has further led to managing a diverse inventory range in the best possible manner. Over the years, the global coding & marking market has undergone various changes, adherence to standards, and other crucial coding terminologies.